| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/02/2005 | CN1572366A Method and apparatus of producing organic compound |
| 02/01/2005 | US6849649 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849632 Heteroaryl alkyl piperazine derivatives |
| 02/01/2005 | US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants |
| 01/27/2005 | WO2005007658A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007628A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2005007618A1 Method for production of $g(a),$g(b)-unsaturated amide compounds |
| 01/27/2005 | WO2005007111A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/27/2005 | WO2005007094A2 Asthma and allergic inflammation modulators |
| 01/27/2005 | WO2005007091A2 Histone deacetylase inhibitors and methods of use thereof |
| 01/27/2005 | WO2004091613A3 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020651 Butyric acid derivatives |
| 01/27/2005 | US20050020624 Dihydroindole and tetrahydroquinoline derivatives |
| 01/27/2005 | US20050020584 Benzamide derivatives as antagonists of orexin receptors |
| 01/27/2005 | US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 01/27/2005 | DE10321255A1 Verfahren zur Herstellung von reinstem rac-1{4-[2- Hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2-diphenylethan-1-one fumarat und reinstes rac-1{4-[2-Hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2 A process for producing the purest rac-1 {4- [2- hydroxy-3- (5-quinolyloxy) propyl] -piperazin-1-yl} -2,2-diphenylethan-1-one fumarate and the purest rac-1 {4 - [2-hydroxy-3- (5-quinolyloxy) propyl] -piperazin-1-yl} -2,2 |
| 01/27/2005 | CA2800212A1 Histone deacetylase inhibitors and methods of use thereof |
| 01/27/2005 | CA2531603A1 Method for production of .alpha., .beta.-unsaturated amide compounds |
| 01/26/2005 | EP1499594A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles |
| 01/26/2005 | EP1499593A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 01/26/2005 | EP1499319A1 Bicyclo 4.4.0 antiviral derivatives |
| 01/26/2005 | EP1446120A4 Stereospecific enrichment of heterocyclic enantiomers |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1569837A Olefin monomer containing 8-hydroxyquinoline metal complex and its production method and use |
| 01/26/2005 | CN1569836A Olefin monomer containing 8-hydroxyquinoline metal complex and its production method and use |
| 01/26/2005 | CN1569835A Production method and use for dichloro quinolinic acid artificial hapten, artificial antigen and specific antibody |
| 01/26/2005 | CN1186344C Amino acid compounds and use thereof as NEP, ACE and ECE inhibitors |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846953 Treating central nervous system disorders such as pain, depression, anxiety, schizophrenia, Huntington's disease, Alzheimer's disease or amyotrophic lateral sclerosis |
| 01/25/2005 | US6846815 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents |
| 01/25/2005 | US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |
| 01/25/2005 | CA2231201C Toilet bowl cleaning tablet |
| 01/20/2005 | WO2005005452A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 01/20/2005 | WO2005005451A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | WO2004099124A3 Novel bioisosteres of actinonin |
| 01/20/2005 | WO2004075858A3 Flavone acetic acid analogs and methods of use thereof |
| 01/20/2005 | WO2004074218A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/20/2005 | WO2004069793A3 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 01/20/2005 | WO2004069792A3 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 01/20/2005 | WO2004026836A3 1-pyridin-4-yl-urea derivatives |
| 01/20/2005 | US20050014947 Method for preparing a 7-quinolinyl-3, 5-dihydroxyhept-6-enoate |
| 01/20/2005 | US20050014945 Reacting an epoxytosylate with 5-hydroxyquinoline; forming 5-(2,3-epoxypropoxy)quinoline ; reacting n-(2,3-diphenylacetyl)piperazine in solvent; salt forming with fumaric acid |
| 01/20/2005 | US20050014839 Histone deacetylase inhibitors and methods of use thereof |
| 01/20/2005 | US20050014793 Pyridinone derivatives for treatment of atherosclerosis |
| 01/20/2005 | US20050014786 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/20/2005 | US20050014721 reacting oxabenzonorbornadiene with nucleophiles;in presence of rhodium complex catalyst forming 2-pyrrolidin-1-ol-1,2-dihydronaphthalen-1-ol; drug used as analgesics, Parkinson's disease, anticancer agents; aids |
| 01/20/2005 | US20050014702 Inhibition of pdf enzyme as bactericidal agents for veterinary medicines |
| 01/20/2005 | DE10329860A1 Sulfonamidderivate polycyclischer Farbstoffe für analytische Anwendungen Sulfonamide derivatives of polycyclic dyes for analytical applications |
| 01/19/2005 | EP1498417A1 Heterocyclic amide derivatives |
| 01/19/2005 | EP1498406A1 Novel hydronaphthalene compounds, prepared by a rhodium catalysed ring opening reaction in the presence of phosphine ligand |
| 01/19/2005 | EP1498139A1 Novel thrombomodulin expression promoters |
| 01/19/2005 | EP1497291A2 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands |
| 01/19/2005 | EP1497266A2 Quinoline derivatives and their use as 5-ht6 ligands |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1412332B1 Quinoline derivatives and use thereof as antitumor agents |
| 01/19/2005 | CN1568314A Process for the preparation of quinoline derivatives |
| 01/19/2005 | CN1185234C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 01/18/2005 | US6844087 Material for use in a light-emitting device and highly efficient electroluminescent device |
| 01/13/2005 | WO2005003095A1 Metal complex compound and organic electroluminescence device containing the same |
| 01/13/2005 | WO2005003086A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 01/13/2005 | US20050010050 Antiinflammatory agents; antiarthritic agents; anticancer agents; analgesics |
| 01/13/2005 | US20050010048 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009870 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders |
| 01/13/2005 | US20050009869 Quinone-indicator antibiotics, particularly2-heptyl-3-hydroxy-4-quinolone, and analogs; regulating the expression of a bacterial gene; modulating bacteria quorum sensing signaling |
| 01/13/2005 | US20050009865 Quinoline derivative as diagnostic probe for disease with tau protein accumulation |
| 01/13/2005 | US20050009818 Therapeutic heterocyclic compounds |
| 01/13/2005 | US20050009815 4-Aminoquinoline compounds |
| 01/13/2005 | US20050009795 Mixtures or organic compounds for the treatment of airway diseases |
| 01/13/2005 | US20050009784 2-(p-oxyphenyl)-6-oxyquinolines, e.g., 2-(3-Fluoro-4-hydroxyphenyl)-4-phenylquinolin-6-ol |
| 01/13/2005 | CA2531327A1 Compounds and therapeutical use thereof |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP0991628B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES |
| 01/12/2005 | EP0944604B1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/12/2005 | CN1564820A Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 01/12/2005 | CN1563004A Compound of quinolone carboxylic acid, preparation method and medicinal usage |
| 01/12/2005 | CN1562973A New method for preparing Aripiprazole |
| 01/11/2005 | US6841681 Process for producing quinoline carboxyaldehyde derivative and intermediate thereof |
| 01/11/2005 | US6841680 2-(Halophenyl)-quinoline derivatives for neuropathic pain; side effect reduction |
| 01/11/2005 | US6841569 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants |
| 01/11/2005 | US6841561 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 01/11/2005 | US6841555 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 01/06/2005 | WO2005000804A2 Substituted indoles and a process for preparing substituted indoles |
| 01/06/2005 | WO2005000109A2 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 01/06/2005 | US20050004367 Sulfonamide derivatives |
| 01/06/2005 | US20050004366 Reacting aniline compound with glyoxylic acid and olefinin presence of solvent using microwave radiation |
| 01/06/2005 | US20050004167 Such as dibenzofuran-2-carboxylic acid 2-(phenylsulfonyl)hydrazide |
| 01/06/2005 | US20050004164 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
| 01/06/2005 | US20050004127 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |
| 01/06/2005 | US20050002485 Method and apparatus of producing organic compound |
| 01/06/2005 | CA2526988A1 Substituted indoles and a process for preparing substituted indoles |
| 01/05/2005 | EP1492787A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them |
| 01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |